BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15544355)

  • 1. The rate of P-glycoprotein activation depends on the metabolic state of the cell.
    Gatlik-Landwojtowicz E; Aänismaa P; Seelig A
    Biochemistry; 2004 Nov; 43(46):14840-51. PubMed ID: 15544355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time monitoring of P-glycoprotein activation in living cells.
    Landwojtowicz E; Nervi P; Seelig A
    Biochemistry; 2002 Jun; 41(25):8050-7. PubMed ID: 12069596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells.
    Aänismaa P; Seelig A
    Biochemistry; 2007 Mar; 46(11):3394-404. PubMed ID: 17302433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.
    Aänismaa P; Gatlik-Landwojtowicz E; Seelig A
    Biochemistry; 2008 Sep; 47(38):10197-207. PubMed ID: 18759452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for monitoring extracellular acidification rates: based on bead injection spectrophotometry and the lab-on-valve system.
    Erxleben HA; Manion MK; Hockenbery DM; Scampavia L; Ruzicka J
    Analyst; 2004 Mar; 129(3):205-12. PubMed ID: 14978521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP occlusion by P-glycoprotein as a surrogate measure for drug coupling.
    Tombline G; Holt JJ; Gannon MK; Donnelly DJ; Wetzel B; Sawada GA; Raub TJ; Detty MR
    Biochemistry; 2008 Mar; 47(10):3294-307. PubMed ID: 18275155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
    Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
    Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
    Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein.
    Fritz F; Howard EM; Hoffman MM; Roepe PD
    Biochemistry; 1999 Mar; 38(13):4214-26. PubMed ID: 10194338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone export from cells: contribution of P-glycoprotein.
    Mitchell AM; Tom M; Mortimer RH
    J Endocrinol; 2005 Apr; 185(1):93-8. PubMed ID: 15817830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microphysiometer for simultaneous measurement of changes in extracellular glucose, lactate, oxygen, and acidification rate.
    Eklund SE; Taylor D; Kozlov E; Prokop A; Cliffel DE
    Anal Chem; 2004 Feb; 76(3):519-27. PubMed ID: 14750842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity.
    Nervi P; Li-Blatter X; Aänismaa P; Seelig A
    Biochim Biophys Acta; 2010 Mar; 1798(3):515-25. PubMed ID: 20004641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ion gradients on H+ transport mediated by human MDR 1 protein.
    Santai CT; Fritz F; Roepe PD
    Biochemistry; 1999 Mar; 38(13):4227-34. PubMed ID: 10194339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and characterization of P-glycoprotein-substrate interactions.
    Gatlik-Landwojtowicz E; Aänismaa P; Seelig A
    Biochemistry; 2006 Mar; 45(9):3020-32. PubMed ID: 16503657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
    Garrigues A; Nugier J; Orlowski S; Ezan E
    Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.